Location: Del Mar, CA
CIK: 0001993440 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $935M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 415,307 | $77.78M | 8.3% | — | — | COM | 76155X100 |
| ABVX | ABIVAX SA | 489,889 | $65.28M | 7.0% | — | — | SPONSORED ADS | 00370M103 |
| AXSM | AXSOME THERAPEUTICS INC. | 218,415 | $53.46M | 5.7% | — | — | COM | 05464T104 |
| ELVN | ENLIVEN THERAPEUTICS INC | 954,360 | $48.43M | 5.2% | — | — | COM | 29337E102 |
| BBIO | BRIDGEBIO PHARMA INC | 633,364 | $47.17M | 5.0% | — | — | COM | 10806X102 |
| ROIV | ROIVANT SCIENCES LTD | 1,331,066 | $47.11M | 5.0% | — | — | SHS | G76279101 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 84,932 | $46.02M | 4.9% | — | — | COM | 91307C102 |
| CYTK | CYTOKINETICS INC | 527,412 | $44.93M | 4.8% | — | — | COM NEW | 23282W605 |
| XENE | XENON PHARMACEUTICALS INC | 600,200 | $36.23M | 3.9% | — | — | COM | 98420N105 |
| CELC | CELCUITY INC | 329,101 | $34.43M | 3.7% | — | — | COM | 15102K100 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,670,000 | $30.68M | 3.3% | — | — | COM | 92790C104 |
| INSM | INSMED INC | 263,851 | $28.13M | 3.0% | — | — | COM PAR $.01 | 457669307 |
| QURE | UNIQURE NV | 608,925 | $28.05M | 3.0% | — | — | SHS | N90064101 |
| ASND | ASCENDIS PHARMA A/S | 104,877 | $27.97M | 3.0% | — | — | ORD SHS | K08588103 |
| PRAX | PRAXIS PRECISION MEDICINES I | 83,528 | $27.96M | 3.0% | — | — | COM NEW | 74006W207 |
| DNTH | DIANTHUS THERAPEUTICS INC | 285,771 | $27.86M | 3.0% | — | — | COM | 252828108 |
| PCVX | VAXCYTE INC | 443,836 | $25.8M | 2.8% | — | — | COM | 92243G108 |
| MIRM | MIRUM PHARMACEUTICALS INC | 218,051 | $25.53M | 2.7% | — | — | COM | 604749101 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 156,450 | $23.91M | 2.6% | — | — | COM | 697947109 |
| COGT | COGENT BIOSCIENCES INC | 602,281 | $23.31M | 2.5% | — | — | COM | 19240Q201 |
| ERAS | ERASCA INC | 1,221,721 | $22.38M | 2.4% | — | — | COM | 29479A108 |
| ORIC | ORIC PHARMACEUTICALS INC | 2,017,284 | $21.85M | 2.3% | — | — | COM | 68622P109 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 582,497 | $19.74M | 2.1% | — | — | ORDINARY SHARES | N62509109 |
| APGE | APOGEE THERAPEUTICS INC | 138,822 | $18.43M | 2.0% | — | — | COM | 03770N101 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 154,018 | $17.1M | 1.8% | — | — | COM | 76243J105 |
| INBX | INHIBRX BIOSCIENCES INC | 164,783 | $15.61M | 1.7% | — | — | COM | 45720N103 |
| SRRK | SCHOLAR ROCK HLDG CORP | 271,227 | $14.92M | 1.6% | — | — | COM | 80706P103 |
| ORKA | ORUKA THERAPEUTICS INC | 155,343 | $14.78M | 1.6% | — | — | COM | 687604108 |
| KYMR | KYMERA THERAPEUTICS INC | 102,533 | $11.76M | 1.3% | — | — | COM | 501575104 |
| SION | SIONNA THERAPEUTICS INC | 110,493 | $4.861M | 0.5% | — | — | COM | 829401108 |
| NUVL | NUVALENT INC | 26,298 | $3.248M | 0.3% | — | — | COM | 670703107 |